Literature DB >> 26002525

Parametric mapping of contrasted ovarian transvaginal sonography.

Katrina Korhonen1, Ryan Moore, Andrej Lyshchik, Arthur C Fleischer.   

Abstract

The purpose of this study was to assess the accuracy of parametric analysis of transvaginal contrast-enhanced ultrasound (TV-CEUS) for distinguishing benign versus malignant ovarian masses. A total of 48 ovarian masses (37 benign and 11 borderline/malignant) were examined with TV-CEUS (Definity; Lantheus, North Billerica, MA; Philips iU22; Philips Medical Systems, Bothell, WA). Parametric images were created offline with a quantification software (Bracco Suisse SA, Geneva, Switzerland) with map color scales adjusted such that abnormal hemodynamics were represented by the color red and the presence of any red color could be used to differentiate benign and malignant tumors. Using these map color scales, low values of the perfusion parameter were coded in blue, and intermediate values of the perfusion parameter were coded in yellow. Additionally, for each individual color (red, blue, or yellow), a darker shade of that color indicated a higher intensity value. Our study found that the parametric mapping method was considerably more sensitive than standard region of interest (ROI) analysis for the detection of malignant tumors but was also less specific than standard ROI analysis. Parametric mapping allows for stricter cutoff criteria, as hemodynamics are visualized on a finer scale than ROI analyses, and as such, parametric maps are a useful addition to TV-CEUS analysis by allowing ROIs to be limited to areas of the highest malignant potential.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26002525      PMCID: PMC4443867          DOI: 10.1097/RUQ.0000000000000125

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  18 in total

1.  Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

Authors:  J Engel; R Eckel; G Schubert-Fritschle; J Kerr; W Kuhn; J Diebold; R Kimmig; J Rehbock; D Hölzel
Journal:  Eur J Cancer       Date:  2002-12       Impact factor: 9.162

2.  The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study.

Authors:  Antonia Carla Testa; Gabriella Ferrandina; Erika Fruscella; Caroline Van Holsbeke; Enrico Ferrazzi; Francesco P G Leone; Domenico Arduini; Caterina Exacoustos; Daniela Bokor; Giovanni Scambia; Dirk Timmerman
Journal:  J Ultrasound Med       Date:  2005-09       Impact factor: 2.153

3.  Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.

Authors:  L Valentin
Journal:  Ultrasound Obstet Gynecol       Date:  1999-10       Impact factor: 7.299

4.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses.

Authors:  S Kupesic; A Kurjak
Journal:  Obstet Gynecol       Date:  2000-09       Impact factor: 7.661

6.  Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.

Authors:  Henri Marret; Stéphane Sauget; Bruno Giraudeau; Molly Brewer; James Ranger-Moore; Gilles Body; François Tranquart
Journal:  J Ultrasound Med       Date:  2004-12       Impact factor: 2.153

7.  Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.

Authors:  Arthur C Fleischer; Andrej Lyshchik; Howard W Jones; Marta A Crispens; Rochelle F Andreotti; Phillip K Williams; David A Fishman
Journal:  J Ultrasound Med       Date:  2009-10       Impact factor: 2.153

8.  Simple ultrasound-based rules for the diagnosis of ovarian cancer.

Authors:  D Timmerman; A C Testa; T Bourne; L Ameye; D Jurkovic; C Van Holsbeke; D Paladini; B Van Calster; I Vergote; S Van Huffel; L Valentin
Journal:  Ultrasound Obstet Gynecol       Date:  2008-06       Impact factor: 7.299

9.  Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.

Authors:  Kenneth J Niermann; Arthur C Fleischer; Jessica Huamani; Thomas E Yankeelov; Dong W Kim; Wendy D Wilson; Dennis E Hallahan
Journal:  J Ultrasound Med       Date:  2007-06       Impact factor: 2.153

10.  Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvements.

Authors:  Arthur C Fleischer; Andrej Lyshchik; Makiko Hirari; Ryan D Moore; Richard G Abramson; David A Fishman
Journal:  J Oncol       Date:  2012-04-26       Impact factor: 4.375

View more
  1 in total

1.  Comparison of tumor angiogenesis in subcutaneous and orthotopic LNCaP mouse models using contrast-enhanced ultrasound imaging.

Authors:  Weiyong Liu; Yunkai Zhu; Lei Ye; Yajuan Zhu; Yuhao Wang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.